BOSTON, December 1, 2023 – Leading international law firm Proskauer is pleased to announce that partner Fangli Chen, Ph.D., has been named a 2024 IAM Global Leader, which features some of the world’s top private practice experts in the field of patents. This marks the third year that Fangli has been to the annual list.
Vice chair of the Firm’s Life Sciences Patent Practice, Fangli represents a range of companies across the biotech and pharmaceutical industries and brings a unique blend of patent prosecution, litigation expertise and sharp business acumen. Her practice focuses on complex portfolio development, post-grant review before the USPTO, oppositions, pre-litigation and litigation strategy, due-diligence investigations, freedom-to-operate, non-infringement and invalidity analysis, licensing and other IP matters in connection with commercial transactions.
Earlier this year, Fangli was named to IAM Patent 1000’s 2023 guide of The World’s Leading Patent Professionals. To qualify for inclusion in the IAM Global Leaders, individuals must be ranked in the gold tier of IAM Patent 1000. Candidates selected for inclusion in IAM Global Leaders are recognized for their ability to innovate, inspire and go above and beyond to deliver value for their clients.
About Proskauer
We are 800+ lawyers serving clients from 12 offices located in the leading financial and business centers in the Americas, Europe and Asia. We work with asset managers, private equity and venture capital firms, Fortune 500 and FTSE companies, major sports leagues, entertainment industry legends and industry-redefining companies.
Since 1875, Proskauer has been devoted to our clients’ successes. Our lawyers are known for their unusually high accessibility, responsiveness and attentiveness. We go the extra mile to understand a client’s business — and think like savvy businesspeople in the process.
Our sophisticated patent team adds value at every stage of the patent development and protection process. Noted for delivering exceptional results, we assist our clients in patent litigation, portfolio development, licensing, technology transfer and strategic counseling. We are one of the few major firms that take plaintiffs' side portfolio work, litigation and licensing, and consistently do it well.
